{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:31:22Z","timestamp":1792665082243,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ophtha.2016.12.015","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T15:53:52Z","timestamp":1484236432000},"page":"488-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience"],"prefix":"10.1016","volume":"124","author":[{"given":"Jasmine H.","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Zabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijah","family":"Mondesire-Crump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Abramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2016.12.015_bib1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib2","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.12.015_bib3","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jamaophthalmol.2015.3119","article-title":"Anterior ocular toxicity of intravitreous melphalan for retinoblastoma","volume":"133","author":"Francis","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/bjophthalmol-2011-300498","article-title":"Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and\/or subretinal seeding: 2-year results","volume":"96","author":"Abramson","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib5","doi-asserted-by":"crossref","first-page":"e84247","DOI":"10.1371\/journal.pone.0084247","article-title":"Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review","volume":"9","author":"Francis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ophtha.2016.12.015_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874364101408010007","article-title":"Death by water: precautionary water submersion for intravitreal injection of retinoblastoma eyes","volume":"8","author":"Francis","year":"2014","journal-title":"Open Ophthalmol J"},{"key":"10.1016\/j.ophtha.2016.12.015_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pbc.21163","article-title":"A\u00a0phase II trial of carboplatin for intraocular retinoblastoma","volume":"49","author":"Dunkel","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ophtha.2016.12.015_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/bjophthalmol-2011-301248","article-title":"ERG monitoring of retinal function during systemic chemotherapy for retinoblastoma","volume":"96","author":"Brodie","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10633-013-9416-8","article-title":"Non-selectivity of ERG reductions in eyes treated for retinoblastoma","volume":"128","author":"Liu","year":"2014","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2016.12.015_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/bjophthalmol-2013-303188","article-title":"Evaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic review","volume":"97","author":"Smith","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib14","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2014.414","article-title":"Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"132","author":"Ghassemi","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2016.12.015_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.OPX.0000145028.53923.67","article-title":"Normal eye growth in emmetropic schoolchildren","volume":"81","author":"Zadnik","year":"2004","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2016.12.015_bib16","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.12-9501","article-title":"Pharmacokinetic analysis of melphalan after superselective ophthalmic artery infusion in preclinical models and retinoblastoma patients","volume":"53","author":"Schaiquevich","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016318310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016318310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T03:58:24Z","timestamp":1536119904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016318310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0161642016318310"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.12.015","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}